High Expression and Clinical Significance of Elafin in Colorectal Cancer

Table 2

Overexpression of Elafin in colorectal cancer patients evaluated by immunostaining scoring in different clinicopathological features.

Group	Tumor					Normal					value
	Total ()	Low (%)		High (%)		Total ()	Low (%)		High (%)
Total	88	20	22.7	68	77.3	88	52	59.1	36	40.9	0.01
Clinical stage
I-II	41	5	12.2	36	87.8	41	16	39.0	25	61.0	0.027
III-IV	47	10	21.3	37	78.7	47	20	42.6	27	57.5	0.076
Tumor invasive
T1-T3	64	11	17.2	53	82.8	64	26	40.66	38	59.4	0.014
T4	24	4	16.7	20	83.3	24	10	41.7	14	58.3	0.18
Lymph node metastasis
N0	42	6	14.3	36	85.7	42	17	40.5	25	59.5	0.027
N1-N2	46	9	19.6	37	80.4	46	19	41.3	27	58.7	0.078
Distant metastasis
M0	83	14	16.9	69	83.1	83	34	41.0	49	59.0	0.005
M1	5	1	20.0	4	80.0	5	2	40.0	3	60.0	—